Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study

Clinical trial NCT05433753 · RECRUITING

Trial details

NCT number: NCT05433753
Sponsor: National Cancer Center, Japan
Status: RECRUITING
Study type: OBSERVATIONAL

HER2-positive Breast Cancer

Start date: 2022-05-24
Primary completion: 2027-09-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.